Retatrutide (60mg) vial
Currently unavailable

Retatrutide

60mg Lyophilised Powder

$549.99AUD per vial

Concentration

60mg

CAS Number

2381089-83-2

Volume Savings

1
Express shipping available Australia-wide
Independently laboratory tested for 99%+ purity

Currently unavailable

Purity as reported on CoA: 99%+

Frequently Bought Together

Retatrutide (10mg)

Support

Retatrutide (10mg)

$139.99

BPC-157 (10mg)

Support

BPC-157 (10mg)

$89.99

GLOW Peptide Blend (50mg)

Support

GLOW Peptide Blend (50mg)

$168.99

Product Information

Retatrutide 60mg Research Peptide – Maximum-Volume Compound for Professional Laboratory Use

Retatrutide (60mg) from Aus Peptide Supply is a high-purity research peptide engineered for professional laboratory environments conducting comprehensive or long-duration in-vitro research programs. Manufactured under strict quality standards, this triple GLP-1/GIP/Glucagon receptor agonist is supplied for scientific investigation and analytical purposes only.

Product Highlights

  • High Purity Standard – Produced using advanced synthesis and purification processes to ensure consistent batch quality at ≥99% purity as reported on the CoA.
  • Research-Grade Quality Control – Subjected to rigorous third-party analytical testing for identity and purity verification via HPLC and mass spectrometry.
  • Secure Packaging – Delivered in sterile, sealed vials engineered to preserve compound integrity across extended storage periods and transport conditions.
  • Reliable Domestic Sourcing – Dispatched from within Australia in compliance with established laboratory handling and quality assurance protocols.

Intended Use

Retatrutide (60mg) is intended exclusively for laboratory research and scientific study. It is not intended for human or veterinary use, therapeutic application, or consumption. Researchers are responsible for ensuring proper handling, storage, and application in accordance with applicable regulations and institutional guidelines.

Storage & Handling

  • Store in a cool, dry environment away from direct light. Lyophilised vials should be kept at -20°C.
  • Reconstitute using appropriate laboratory-grade solvents (such as bacteriostatic water) where applicable.
  • Follow standard laboratory safety procedures when handling peptide compounds.

For research facilities requiring maximum compound availability in a single verified vial, Retatrutide (60mg) offers the highest-volume format in the range — same purity standard, same batch-specific CoA documentation, at the most efficient cost per milligram. Fast domestic shipping to all Australian states and territories, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.

Frequently Asked Questions

What is Retatrutide?
Retatrutide is a synthetic peptide that acts as a triple agonist at the GLP-1, GIP, and glucagon receptors simultaneously. This tri-receptor activity profile is what separates it from earlier compounds like semaglutide (GLP-1 only) and tirzepatide (GLP-1/GIP), and is the basis for the significant fat loss results observed in Phase 2 clinical trials.
Why choose the 60mg vial?
Simple: it's the best value format we offer, and it's enough for a full extended protocol without running out. At $559.99 for 60mg — roughly $9.33 per milligram — you're getting six times the compound compared to a single 10mg vial, for about four times the price. If you're planning a 12-week or longer research window, the 60mg vial means one order, one batch, consistent purity from start to finish. No reordering mid-protocol, no waiting on restocks.
What does the research show about Retatrutide?
Phase 2 clinical trials observed mean body weight reductions of up to 24% over 48 weeks — significantly outperforming semaglutide and tirzepatide in head-to-head comparisons. Subjects also showed dramatic reductions in waist circumference, visceral fat, and improvements across key cardiometabolic markers. The appetite suppression observed was described as profound, with energy intake reductions sustained throughout the trial period. No other compound in its class has matched these results in clinical trial data.
How does Retatrutide work?
Retatrutide hits three separate pathways at once — GLP-1 receptors to suppress appetite and slow digestion; GIP receptors to improve insulin sensitivity and amplify fat loss; and glucagon receptors to increase energy expenditure by driving the liver to burn more fuel. Most weight loss compounds only target one or two of these. Retatrutide targets all three simultaneously, which is why the Phase 2 results were so far ahead of anything that came before it.
How does Retatrutide compare to semaglutide and tirzepatide?
Semaglutide (Ozempic/Wegovy) is a GLP-1 only agonist — one receptor. Tirzepatide (Mounjaro) targets GLP-1 and GIP — two receptors. Retatrutide targets GLP-1, GIP, and glucagon — three receptors. In Phase 2 trials, Retatrutide produced a mean 24% body weight reduction over 48 weeks; tirzepatide achieved around 20% in comparable studies, and semaglutide around 14–15%. The addition of glucagon receptor activity — which drives energy expenditure directly — is the key difference.
How do you reconstitute Retatrutide?
Retatrutide is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) immediately before use. Inject the BAC water slowly into the vial, directing the stream down the inside wall. Gently swirl to dissolve — do not shake. Once reconstituted, store at 2–8°C and use within 28 days. For a full step-by-step walkthrough, see our complete peptide reconstitution guide.
How should Retatrutide be stored?
Store lyophilized Retatrutide vials at -20°C, away from light and moisture. After reconstitution, refrigerate at 2–8°C and use within 28 days. Do not freeze reconstituted solution.
Where to buy Retatrutide 60mg in Australia?
Retatrutide (60mg) is available through Aus Peptide Supply with fast domestic shipping to all Australian states and territories. Every vial is dispatched from within Australia — no customs delays, no international freight uncertainty. Each batch undergoes third-party analysis and the Certificate of Analysis is available to view in our CoA library.
What is the cost per milligram of Retatrutide at 60mg?
Retatrutide (60mg) is priced at $549.99 per vial, which works out to approximately $9.17 per milligram at Aus Peptide Supply.

Purchase Other Quantities

Retatrutide is also available in other vial sizes. Compare the current formats below and jump straight to the quantity that fits your protocol.

Retatrutide (10mg)

PEP-007-10MG

$139.99

Available to purchase now

View this quantity →

Retatrutide (20mg)

PEP-024-20MG

$229.99

Currently unavailable

View this quantity →

Retatrutide (30mg)

PEP-019-30MG

$329.99

Currently unavailable

View this quantity →

Retatrutide (60mg)

PEP-025-60MG

Current

$549.99

Currently unavailable

Viewing this quantity →